Retelliptine, formerly known as BD-84; NSC-D-626717-W; SR-95325B (diHCl); SR-95325A (dimaleate); is a DNA topoisomerase II inhibitor potentially for the treatment of cancer. References: Kattan J, Durand M, Droz JP, Mahjoubi M, Marino JP, Azab M. Phase I study of retelliptine dihydrochloride (SR 95325 B) using a single two-hour intravenous infusion schedule. Am J Clin Oncol. 1994 Jun;17(3):242-5. PubMed PMID: 8192111.

纯度：≥98%

CAS：72238-02-9